DE1020341B - Process for the preparation of imidazolidone derivatives - Google Patents
Process for the preparation of imidazolidone derivativesInfo
- Publication number
- DE1020341B DE1020341B DEM32684A DEM0032684A DE1020341B DE 1020341 B DE1020341 B DE 1020341B DE M32684 A DEM32684 A DE M32684A DE M0032684 A DEM0032684 A DE M0032684A DE 1020341 B DE1020341 B DE 1020341B
- Authority
- DE
- Germany
- Prior art keywords
- parts
- methanol
- cyan
- acetone
- room temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 9
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical class O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims description 3
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 26
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 13
- 229940109239 creatinine Drugs 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 150000005840 aryl radicals Chemical class 0.000 claims description 10
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 9
- BTKSUULMJNNXHG-UHFFFAOYSA-N ethyl 2-(methylamino)acetate Chemical compound CCOC(=O)CNC BTKSUULMJNNXHG-UHFFFAOYSA-N 0.000 claims description 9
- -1 fatty acid esters Chemical class 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 150000003254 radicals Chemical class 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 150000003141 primary amines Chemical class 0.000 claims description 3
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 33
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 18
- 239000007795 chemical reaction product Substances 0.000 claims 6
- 239000011541 reaction mixture Substances 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 238000002844 melting Methods 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- 239000012043 crude product Substances 0.000 claims 3
- 230000008018 melting Effects 0.000 claims 3
- 239000000047 product Substances 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- 238000010626 work up procedure Methods 0.000 claims 3
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 claims 2
- 238000003756 stirring Methods 0.000 claims 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims 1
- 108010077895 Sarcosine Proteins 0.000 claims 1
- 235000011114 ammonium hydroxide Nutrition 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 239000013078 crystal Substances 0.000 claims 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims 1
- QPJDMGCKMHUXFD-UHFFFAOYSA-N cyanogen chloride Chemical compound ClC#N QPJDMGCKMHUXFD-UHFFFAOYSA-N 0.000 claims 1
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 150000004683 dihydrates Chemical class 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical compound CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000012442 inert solvent Substances 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- RTWNYYOXLSILQN-UHFFFAOYSA-N methanediamine Chemical compound NCN RTWNYYOXLSILQN-UHFFFAOYSA-N 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N methyl pentane Natural products CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000004682 monohydrates Chemical class 0.000 claims 1
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 claims 1
- 239000003495 polar organic solvent Substances 0.000 claims 1
- 239000002798 polar solvent Substances 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 229940043230 sarcosine Drugs 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 230000007704 transition Effects 0.000 claims 1
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Landscapes
- Pyrrole Compounds (AREA)
Description
DEUTSCHESGERMAN
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von Imidazolidonderivaten der allgemeinen FormelThe present invention relates to a process for the preparation of imidazolidone derivatives of the general formula
R9 — CH — C = OR 9 - CH - C = O
N-R-1 NR -1
R2-CH-CO-OR1 R 2 -CH-CO-OR 1
R3 R 3
Verfahren zur Herstellung
von ImidazolidonderivatenMethod of manufacture
of imidazolidone derivatives
NHNH
worin R2 ein Wasserstoffatom, einen Alkyl-, Aralkyl- oder Arylrest, R3 einen Alkyl-, Aralkyl- oder Arylrest und R4 ein Wasserstoffatom, einen Alkyl-, Aralkyl-, Arylrest oder einen Rest —(C H2) m —Y, mit η = eine ganze Zahl, vorzugsweise 2 bis 10, und Y = die obenstehende Formel ohne R4 bedeutet. Einer der wichtigsten Vertreter dieser Substanzklasse, bei dem in obenstehender Formel R2 und R4 Wasserstoffatome und R3 eine Methylgruppe sind, ist der Naturstoff Kreatinin.wherein R 2 is a hydrogen atom, an alkyl, aralkyl or aryl radical, R 3 is an alkyl, aralkyl or aryl radical and R 4 is a hydrogen atom, an alkyl, aralkyl, aryl radical or a radical - (CH 2 ) m —Y , with η = an integer, preferably 2 to 10, and Y = the above formula without R 4 . One of the most important representatives of this class of substances, in which R 2 and R 4 are hydrogen atoms and R 3 is a methyl group in the above formula, is the natural substance creatinine.
Kreatinin wird technisch meist aus Kreatin gewonnen, das aus tierischen Naturstoffen erhalten werden kann, aber auch auf synthetischem Wege leichter zugänglich ist als Kreatinin. Es ist auch bekannt, daß Kreatinin durch Umsatz von Sarkosinsäureäthylester mit Cyanamid bei Raumtemperatur hergestellt werden kann. Gemäß einem anderen bekannten Verfahren können Kreatinin und dessen Homologe bzw. Derivate durch Umsetzung von monosubstituierten Natrium-Cyanamiden und ct-Halogenacetamid hergestellt werden. Diese beiden letztgenannten Verfahren haben aber den Nachteil, daß die Ausgangsstoffe nicht einfach zugänglich sind.Technically, creatinine is usually obtained from creatine, which can be obtained from natural animal substances, but is also more easily accessible by synthetic means than creatinine. It is also known to be creatinine can be prepared by reacting ethyl sarcosinate with cyanamide at room temperature. According to another known method, creatinine and its homologues or derivatives can by Implementation of monosubstituted sodium cyanamides and ct-haloacetamide are produced. These two However, the latter processes have the disadvantage that the starting materials are not easily accessible.
Es konnte nun überraschenderweise gefunden werden, daß sich Verbindungen der allgemeinen Formel I auf besonders einfache Weise synthetisieren lassen, wenn man N-substituierte a-Cyanaminofettsäureester der Formel Anmelder:It has now surprisingly been found that compounds of the general formula I arise can be synthesized in a particularly simple manner if one uses N-substituted α-cyanoamino fatty acid esters of the formula Applicant:
Lentia Gesellschaft
mit beschränkter Haftung,Lentia society
with limited liability,
Ein- und Verkauf,
München 15, Mittererstr. 3Buying and selling,
Munich 15, Mittererstr. 3
Beanspruchte Priorität:
Österreich vom 30. Oktober 1956Claimed priority:
Austria from October 30, 1956
Dr. Walter Stockmair, Linz,Dr. Walter Stockmair, Linz,
und Dr. Otto Schmid, Leonding bei Linz (Österreich), sind als Erfinder genannt wordenand Dr. Otto Schmid, Leonding near Linz (Austria), have been named as inventors
Kreatinin auf einfachstem Wege durch Umsetzung von Cyansarkosinsäureestern der FormelCreatinine in the simplest way by converting cyan sarcosinic acid esters of the formula
CH2-CO-OR1 CH 2 -CO-OR 1
in der R1 einen Alkyl-, Aralkyl- oder Arylrest bedeutet und R2 und R3 die oben angegebene Bedeutung haben, mit Ammoniak oder primären Aminen der Formel R5-NH2 umsetzt, wobei R5 einen Alkyl-, Aralkyl- oder Arylrest oder den Rest —(CHa)n -NH2 darstellt, wobei η die oben angegebene Bedeutung hat.in which R 1 is an alkyl, aralkyl or aryl radical and R 2 and R 3 have the meaning given above, with ammonia or primary amines of the formula R 5 -NH 2 , where R 5 is an alkyl, aralkyl or aryl radical or represents the radical - (CHa) n -NH 2 , where η has the meaning given above.
Gemäß dem erfindungsgemäßen Verfahren kann also CH3-NAccording to the process according to the invention, CH 3 -N
N= CN = C
in der R1 die oben angegebene Bedeutung hat, mit Ammoniak in guter Ausbeute und großer Reinheit hergestellt werden. Durch entsprechende Variation der Substituenten R2, R3 oder R4 bzw. R5 sind aber auch viele, zum Teil bisher unbekannte Derivate des Kreatinins leicht zugänglich geworden. So gelangt man beispielsweise durch die erfindungsgemäße Umsetzung von N-substituierten a-Cyanaminofettsäureestern mit Diaminen der allgemeinen Formel R6NH2, in denen R5 den Rest — (CH2)« — NH2 bedeutet, wobei beide Aminogruppen des Diamins mit den a-Cyanaminofettsäureestern reagieren, zu bisher unbekannten Kreatininderivaten nachstehender Formel mit zwei Kreatininresten im Molekül.in which R 1 has the meaning given above, can be prepared with ammonia in good yield and high purity. By correspondingly varying the substituents R 2 , R 3 or R 4 or R 5 , however, many derivatives of creatinine, some of which were previously unknown, have become easily accessible. For example, the inventive reaction of N-substituted α-cyanoamino fatty acid esters with diamines of the general formula R 6 NH 2 , in which R 5 denotes the radical - (CH 2 ) - NH 2 , both amino groups of the diamine having the a -Cyanamino fatty acid esters react to form previously unknown creatinine derivatives with the following formula with two creatinine residues in the molecule.
R2-CH-C = O O = C CH-R2 R 2 -CH-C = OO = C CH-R 2
R3 _ N N-(CHJn-N N-R3 R 3 _ N N- (CHJ n -N NR 3
R3 undR 3 and
NH NHNH NH
haben die oben angegebene Bedeutung).have the meaning given above).
709 808/261709 808/261
Claims (3)
wäßrigen Ammoniaklösung mit einem Gehalt von .46.5 parts of N-cyan sarcosine ethyl ester are added to a micro-melting point (Kofler apparatus) of about stirring in 115 parts of a 320 ° cooled to -1 to -5: with decomposition,
aqueous ammonia solution with a content of.
Temperatur stehengelassen. Das ausgefallene Kreatinin
wird abgesaugt, mit Alkohol gewaschen und anschließend9.3 parts of N-cyan sarcosine ethyl ester are added at -10 ° with 120 parts of acetone. 19.9 parts are obtained dropwise in 40 parts of ethanol, 6.7 parts of pure ammonia product. The substance forms a monohydrate with dissolved contained, registered and 15 hours at this 5o a melting point of 122 to 127 °.
Temperature left to stand. The failed creatinine
is suctioned off, washed with alcohol and then
stehen. Das kristallin ausgefallene Reaktionsprodukt wird
durch Absaugen isoliert, mit Aceton gewaschen und
getrocknet. Man erhält 14,8 Teile rohes 3-Benzyl- 65 worin R2 ein Wasserstoffatom, einen Alkyl-, Aralkylkreatinin; das entspricht einer Ausbeute von 72,9% der oder Arylrest, R3 einen Alkyl-, Aralkyl- oder Arylrestketone added and left for a further 4 days at room temperature
stand. The crystalline precipitated reaction product is
isolated by suction, washed with acetone and
dried. 14.8 parts of crude 3-benzyl- 65 are obtained in which R 2 is a hydrogen atom, an alkyl or aralkyl creatinine; this corresponds to a yield of 72.9% of the or aryl radical, R 3 an alkyl, aralkyl or aryl radical
R8-NR 2 -CH
R 8 -N
umsetzt.in which R 1 is an alkyl, aralkyl or aryl radical and R 2 and R 3 have the meaning given above, with ammonia or primary amines of the formula R 5 ■ NH 2 , in which R 5 is an alkyl, aralkyl or aryl radical or
implements.
CH,- NCH 2 -CO-OR 1
CH, - N
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT1020341X | 1956-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1020341B true DE1020341B (en) | 1957-12-05 |
Family
ID=3684193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEM32684A Pending DE1020341B (en) | 1956-10-30 | 1956-12-18 | Process for the preparation of imidazolidone derivatives |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE1020341B (en) |
-
1956
- 1956-12-18 DE DEM32684A patent/DE1020341B/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE819093C (en) | Process for the production of thyroxine and its derivatives | |
| DE1261511B (en) | Process for the preparation of amidic acid esters of divalent carboxylic acids | |
| DE1212984B (en) | Process for the production of basic substituted coumarones | |
| DE1020341B (en) | Process for the preparation of imidazolidone derivatives | |
| DE1670163C3 (en) | Cephaloglycindenvate and process for its preparation | |
| CH522651A (en) | (A) Cpds:- W = NO2, CN, H, or Ph P = H or NO2, with the proviso that at least one of W and P = NO2 Q = alkylene, alkenylene, aralkylene, or alkylidene R = alky | |
| CH383948A (en) | Process for making new hydrazones | |
| CH365082A (en) | Process for the preparation of imidazole derivatives | |
| DE3411202C2 (en) | Process for the preparation of 2-amino-s-triazines | |
| DE437976C (en) | Process for the preparation of alkamine esters of N-monoalkylated and N-monoalkyloxyalkylated derivatives of p-aminobenzoic acid | |
| DE1670143C3 (en) | ||
| DE850297C (en) | Process for the preparation of amidine salts | |
| DE1247294B (en) | Process for the preparation of 2-chloro-3-oxobutyric acid amides | |
| DE857498C (en) | Process for the preparation of quaternary amines | |
| DE1140583B (en) | Process for the preparation of o- [bis- (2-chloroethyl) -amino] -phenyl-alanine | |
| DE1543942C (en) | Process for the preparation of 1 Oxa 2 methyl 3 carbonylarmno 4 tnia cyclohe xen (2) en | |
| DE1918042C3 (en) | beta, beta, beta-trichloroethylideneamine derivatives | |
| DE1695757C3 (en) | Pyridine methanol carbamates and processes for their preparation | |
| DE2137649B2 (en) | ||
| AT230542B (en) | Process for the manufacture of hydroxypenicillins | |
| AT278779B (en) | Process for the preparation of new 3-amino-tetrahydroindazoles and their salts | |
| DE1247304B (en) | Process for the production of guanidine derivatives | |
| AT249048B (en) | Process for the preparation of new benzimidazolone derivatives | |
| DE2019844A1 (en) | Fungitoxic formylaminals | |
| DE1953059A1 (en) | Carbamic acid derivatives and processes for making the same |